2nd coronavirus vaccine shows early success in U.S. tests
FILE – In this July 30, 2020 photo, Kai Hu, a research associate transfers medium to cells, in the laboratory at Imperial College in London. Imperial College is working on the development of a COVID-19 vaccine. In a report to Congress and an accompanying “playbook” for states and localities, key federal health agencies and the Defense Department sketched out complex plans for a vaccination campaign to begin gradually early next year or later in 2020, eventually ramping up to reach any American who wants a shot. The Pentagon is involved with the distribution of vaccines, but civilian health workers will be the ones giving shots. (AP Photo/Kirsty Wigglesworth)
There’s more promising news on the COVID-19 vaccine front as Moderna says its shot provides strong protection against the coronavirus.
Monday’s announcement comes a week after a competitor, Pfizer, revealed its own vaccine to be similarly effective. The announcements come as the virus surges in the U.S. and around the world. Moderna said of 95 infections so far in its 30,000-person study, all but five were in people who got dummy shots.
Both Moderna and Pfizer are on track to seek permission for emergency use in the U.S. within weeks. Still, initial supplies will be limited and rationed.